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1049-110 Influence of Diabetes Mellitus on Intravenous 
Thrombolysis Effectiveness in Patients With ST 
Elevation Myocardial Infarction 
Michael N. Zairis, Olga Papadaki, Stamatis Makrygiannis, Olga Ampartzidou, Pelagia 
Batika, Athanasios J. Manolis, Demetrios Beldekos, Christina Festeridou. Neophytos 
Kassinos, Stelios Handams, Apostolos Papantonakos, Stefanos Fouussas, Tzanio 
Hospital, Piraeus, Greece 
Background-Early resolution of ST-segment elevation is associated with enhanced clin- 
ical outcome following ST elevation myocardial infarction (STEMI). Despite the improve- 
ments in the management of type 2 diabetic patients with STEMI these patients have 
unfavorable prognosis. The present prospective study investigated the hypothesis that 
type 2 diabetic patients may have a delayed ST-segment recovery during administration 
of intravenous thrombolysis even though within the desirable margin. 
Methods-The study cohort included 137 consecutive patients with STEMI; 105 were 
non-diabetic and 32 type 2 diabetic. All patients received thrombolysis in r6 hours from 
index pain and attained steady 250% ST-segment recovery within 90min. The course of 
ST-segment recovery was assessed utilizing continuous 12.lead electrocardiographic 
monitoring. 
Results-The time required for 250% ST-segment steady resolution was significantly 
greater in type 2 diabetics (P <O.OOi). Additionally, although there was no difference in 
the mcidence of TIMI 2 or 3 flow between the two groups, type 2 diabetics had signifi- 
cantly higher values of corrected TIMI frame count in the infarct-related arteries (P 
<O.OOl). By multwariate linear regression analysis diabetes mellitus was independently 
and positively related to the time for 150% ST-segment recovery (P ~0.001). 
Conclusions-The present study implies that type 2 diabetic patients may have delayed 
recovery of ST-segment elevation even dunng successful thrombolysis. 
1049-l 11 The Clinical Significance of Circulating Levels of 
Granulocyte/Macrophage-Colony Stimulating Factor in 
Acute Myocardial Infarction Patients 
Konstantinos I. Kaoetanios, Christos E. Pitsavos. Stamatis Kastelanos, Grigorios P. 
Vyssoulis, Demosthenes B. Panagiotakos. Emanuel V. Economou, Marina G. Toutouza 
Christodoulos Stefanadis, Pavlos K. Toutouzas, Hippokration Hospital, University of 
Athens Medical School, Athens. Greece 
Background: Despite recent advances in our understanding of ischemia-induced angio- 
genie procsss, the in situ formation of blood vessels from circulating endothelial progeni- 
tor cells or hemangioblasts (vasculogenesis) due to ischemia, remains an unsettled 
issue. Therefore, we investgated the role of granulocytelmacrophage- colony stimulating 
factor (GM-CSF), a hemopoletic agent with vasculogenic properties, in acute myocardial 
infarction (AMI) patients (pts). 
Methods: 29 pts with first attack of AMI admitted and thrombolysed during the acute 
phase, were examined for plasma levels of GM-CSF, measured by ELISA, and corn- 
pared to 20 normal controls (NC) with mean values 3,15 f 0,28 pg/ml. All pts were 
divided in 2 sex and age- matched groups. Group A: 15 pts with minor AMI, E.F>45% 
and no subsequent L.V dysfunction. Group B: 14 pts with large infarct size. E.Fc45% and 
residual heart failure. Plasma samples were collected on hospital admission (0 hours) as 
well as 3h. 6h. 9h. 12h. 18h. 24h. 36h. 48h. 3 davs. 4d. 56, 7d. 15d and 30d thereafter. 
Rest&: Data is expressed as mean values + S;M in pg/ml. For the statistical analysis 
the Wilcoxon test was used with rxO.05 cornoared to NC (‘1 and the relevant lowest ,. 
value at 24h (A). Group A exhibited a slight non significant GM-CSF increase (3,92 + 
0,83) at Oh, followed by a gradual decrease reachmg a nadir at 24h (2,87 _+ 0,42) which 
was reversed leading to a late significant peak at 5d (10,722 1,93 *A). In contrast, group 
B developed a significant initial peak (8,56 + 1,44 * ^) succeeded by a gradual decrease 
reachmg a nadir at 24h (2,98 -+ 0,32) followed by a slight non significant peak at 7d (4,08 
+ 1,25). 
Conclusions: All pts developed high initial GM-CSF levels, but only in group B this 
increase was significant compared to NC and the lowest plasma value at 24h. This early 
increase in group B may account for macrophage recruitment leading to macrophage- 
induced L.V dysfunction in the early post-AM1 period. A late GM-CSF rebound at 5d is 
significant only in group A probably implying that vasculogenesis is enhanced, thus pra- 
serving L.V function and exerting a cardioprotective potential, while it remains practically 
absent in pts with extensive AMI, thus resulting in L.V decompensation. 
1049-112 Primary Angioplasty Under Distal Protection Is a Useful 
Strategy lo Obtain Optimal Myocardial Reperfusion 
Compared to the Primary Angioplasty With 
Thrombectomy Device in Acute Myocardial Infarction 
Patients 
Hirotaka Komatsu Masato Nakamura, Naokl Ito, Takahiro Tsuji. Masato Yamamoto, 
Hidehiko Ham, Hisao Ham, Hironori Hirai, Toho University Oohashi Hospital, Tokyo, 
Japan 
Backgrounds: Recent studies demonstrated that distal embolization during angioplasty 
may deteriorate the tissue perfusion. Therefore, much attention has been paid on the 
strategies to prevent distal embolization. The aim of this study was to define the efficacy 
of distal protection system to obtain optimal myocardlal reperfusion in patients underwent 
primary angioplasty. 
Methods: A total of 53 acute myocardial Infarction (AMI) patient underwent primary 
angioplasiy were enrolled in this study. Primary angioplasty under distal protection was 
performed m 27 cases (DP group), and primary angioplasty with thrombectomy device 
(RescueTM) was in 28 cases (Rescue group). The degree of optimal myocardial reperiu- 
Sion was assessed by means of early ST-segment resolution, and was compared 
between 2 groups. The ST-segment elevation was measured from ECG at admission 
and 1 hour after primary angioplasty and ST-segment resolution was calculated. 
Results: Baseline characteristics were not different in both groups. 
Conclusions: DP group showed greater ST resolution compared to Rescue group. 
These data may indicate primary angioplasty under distal protection is more effective 
strategy to prevent and reduce microembolization in patients with AMI. 
DP(n=27) Rescue(n=ZB) 
ST resolution(%) 71.4k27.3 48.1+33.9 p=o.o07 
complete@70%) 17(83%) 7(29%) p=o.o07 
partial(c70%. ~30%) 7(26%) 12(46%) NS 
llO(<30%) 3(11%) 7(27%) NS 
Peak CK(mg/dl) 3283+2848 2865+2425 NS 
1049-113 lntracoronary Hyperoxemic Blood Infusion Following 
Primary Percutaneous Coronary Intervention in 
Anterior Acute Myocardial Infarction Patients: Positive 
Effects on Cardiac Enzyme Kinetic, ST-Segment 
Changes, and Left Ventricular Function Recovery 
DanielaTrabanoni, France Fabbiocchi, Piero Montorsi, Giancarfo Marenzi, Alessandro 
Loaldi, Paolo Ravagnani. Fabrizio Celeste, Stefano Galli, Luca Grancini, Antonio L. 
Bartorelli, Centro Cardiologico Monzino, Institute of Cardiology, Milan. Italy 
Aim: To assess cardiac enzyme kinetic. ST-segment evolutionary changes and LV func- 
tion recovery in primary PCI pts treated with intracoronary hyperoxemic blood infusion 
and compare them with the results obtained in matched control pts. 
Methods: We studied 41 pts treated by primary PCI for ST-elevation anterior AMI. In 21 
pts (A0 group), hyperoxemic blood (~02: 760-1000 mmHg) was selectively infused with 
the TherOx A0 System via a 4F infusion catheter for 90 min into the LAD Immediately 
after coronary recanalization. The remainmg 20 pts (control group) had spontaneous nor- 
moxemicblood autoperfusion. The two groups were matched in clinical and angiographic 
characteristics and showed similar pre-procedural LV function (PD.echo) and no signifi- 
cant difference in time to presentation (A0 group: 3.5+1.6 hrs; control group: 2.75+1.77 
hrs) and maximum ST elevation (A0 group: 6.2+3.6 mm; control group: 5.6+3.2 mm). LV 
function recovery was evaluated by serial 2-D echo (EF and WMSI) at 24 hrs, 7 days and 
6 months in both groups. 
Results: LAD recanalization (100% stenting) was successful in all pts. No difference was 
observed in CK peak levels between A0 group (3609+2214 IUII) and control group 
(4024+2649 lU/l). However, A0 group showed a 4.8+2.2 hrs shorter time to peak CK 
release (p=O.OOl) and a shorter CK half-life period (23.4+8.9 vs. 30.5~5.8 hrs, p=O.OOS) 
compared to the control group. Furthermore, A0 group had more significant reduction of 
ST-segment elevation after LAD recanalization (5.2+0.8 mm vs. 0.95+2.2, p=O.O2). Com- 
pared to baseline values, a significant mean relative improvement of LV function (% EF) 
at 24 hrs, 7 days and 6 months was observed only in A0 pts (AO: 13.6% 17.8% and 
24.5%, respectively) while control pts did not show any significant change (2.4%, 4.5% 
and 2.5% respectively). 
Conclusion: After successful primary PCI, cardiac enzyme kinetic and ST-segment evo- 
lutlonary changes in A0 treated pts suggest faster and more complete microvascular 
reperfusion. This may explain the signlflcantly better LV function recovery I” A0 treated 
pts compared to controls. 
